# Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

> **NCT00988312** · PHASE1 · COMPLETED · sponsor: **University Hospital Carl Gustav Carus** · enrollment: 9 (actual)

## Conditions studied

- Multiple Myeloma
- Plasmocytoma

## Interventions

- **BIOLOGICAL:** autologous idiotype-protein pulsed dendritic cells

## Key facts

- **NCT ID:** NCT00988312
- **Lead sponsor:** University Hospital Carl Gustav Carus
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-02
- **Final completion:** 2004-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2009-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988312, "Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00988312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*